Boehringer Ingelheim joined with two China animal health companies to form a $134 million JV to address foot-and-mouth disease in pigs, cattle and sheep. Boehringer Ingelheim will contribute its vaccine technology to the JV, which will be located in Xi’an and called Shaanxi Meili Omni-Honesty Animal Health. The JV expects to begin production of the vaccine in 2021. Boehringer Ingelheim will be joined by Beijing KangMu Omni-Honesty Animal Health Products (KMOH), and China Agricultural Vet. Bio. Science and Technology (ZNWT).
Source: China Biotoday
